Skip to main content
. 2016 May 25;11(5):e0156221. doi: 10.1371/journal.pone.0156221

Fig 1. Overall survival.

Fig 1

Kaplan Meier estimates of overall survival evaluated from the date of lapatinib-based therapy initiation in 132 patients according to PFS >7 months (solid line) or PFS ≤7 months (dashed line). Median overall survival is 36 months (95% C.I. 9–21 months) and 15 months (19–53 months), respectively (p<0.001).